Home Page Biographical Sketch Awards & Distinctions Intellectual Property Advisory 
Boards		 Invited Presentations National & International Activities Publications List & Index Books


Thomas Tobin
Invited Presentations

Thomas Tobin has presented over 250 invited presentations worldwide.
The following listing starts in January 1999, at presentation # 195.


195.   Analytical Techniques in Racing Chemistry" BHP Laboratories, Limerick, Ireland.
           January 8th, 1999.

  1. Limitations of the Sensitivity of Testing". Presentation to Harness Racing Stewards, Perth, WA, January 11th, 1999.
  2. Clenbuterol: Review of current research in this area. Presentation to the Medication Committee, National Horsemen’s Benevolent & Protective Association, January 16th, Ft. Lauderdale, FL.
  3. Seminar for Merial on introduction of Omeprazolie in Equine Market. Boston, MA, February 26,1999.
  4. "Panel of Experts on Medication" March 6th, 1999, Orlando Florida. Thomas Tobin, Richard Sams, George Maylin, and Thomas Lomangino. Hosted by Stan Bergstein of Harness Tracks of America.
  5. Six plus presentations to the Association of Official Racing Chemists on Drug Testing in Racing Horses, March 10th - March 16th, 1999, New Orleans, Louisiana
  6. Presentation on Drug Testing and medication control, March 26th, 1999, Dover, Delaware, Seminar @ Delaware Harness Commission Offices.
  7. Seminar on Medication Control, June 24, 25th, 26th, 1999, Boston, MA for The Controlled Release Society.
  8. Attendance at the National Council of Legislators from Gaming States (NCLGS) Seminar, July 11th, 1999, Louisville, KY
  9. Presentation on Clenbuterol, July 16th - 17th, 1999, Chicago, Illinois. Association of Racing Commissioners International (ARCI) Workshop.
  10. Attendance at Summer Meeting of The Horsemen’s Benevolent and Protective Association Meeting, August 2nd - 6th, 1999, Seattle, Washington.
  11. Presentation to Thoroughbred Owners of California, Del Mar Racetrack, August 7th, 1999, San Diego, California.
  12. "Seminar on Clenbuterol"; August 21st, 1999; Association of Racing Commissioners International, Del Mar Hilton; San Diego, CA
  13. Presentation on Clenbuterol Regulation. October 9th - 11th, 1999, Palm Beach, FL. Presentation on Clenbuterol Regulation. National Association of Parimutual Regulators.
  14. Presentation on "Equine Medication Control: Clenbuterol and Cocaine." National HBPA Meeting, New Orleans, LA, January 30 - February 1, 2000.
  15. "SuperTesting": Seminar at the Gluck Equine Research Center with Mr. James Gallagher of the NTRA February 7th, 2000.
  16. Organization of Racing Investigators, Keeneland, Lexington, KY. "Past, Present and Future of Horse Drug Testing". Wednesday, March 22nd, 2000.
  17. Testing Integrity Program, Davis, California. March 30th - April 1, 2000. Presentations on Clenbuterol, Cocaine and Pyrilamine.
  18. "Therapeutic Medication of Racing Horses: A Short Course"; Kentucky Racing Commission/Kentucky Racing Commission/Kentucky Equine Drug Council. Short Course, Three Hours. Keeneland, April 21st, 2000.
  19. New Directions in Equine Drug and Medication Testing. Equine Law Section of the Kentucky Bar Association. Marriott Griffin Gate, May 3, 2000.
  20. "Therapeutic Medication of Racing Horses: A Short Course": Kentucky Racing Commission/Kentucky Racing Commission/Kentucky Equine Drug Council. Short Course, Three Hours. Churchill Downs, June 8, 2000.
  21. Invited presentation and discussion group on Product Entry into the Equine Market, Boehringer/3M at the 3M Corporate Retreat, Wonewok, Wisconsin, June 9-12, 2000.
  22. Representing the Department and the College of Agriculture at the "Memoire" of Mr. Cedric Holtz, Dijon, France, July 26, 2000.
  23. Review of Equine Research. National Horsemen’s Benevolent and Protective Association, Minneapolis, Minnesota, August 4, 2000. Charles Hughes and Thomas Tobin
  24. Clenbuterol in the Horse: An Overview. The 3M Corporation, Minneapolis, Minnesota, August 5, 2000. Charles Hughes and Thomas Tobin.
  25. Invited presentation to 13th International Conference of Racing Analysts and Veterinarians. "No Effect Levels – an Overview and a Pharmacological Approach." Cambridge, England, August 9, 2000.
  26. "Therapeutic Medication of Racing Horses: A Short Course": Kentucky Racing Commission/Kentucky Racing Commission/Kentucky Equine Drug Council. Short Course, Three Hours. Ellis Park, June 8, 2000.
  27. Eighth Testing Integrity Workshop. "High Sensitivity and High Throughput ELISA and Mass Spectral Analysis." Lexington, Kentucky. October 6,7, and 8, 2000.
  28. "Therapeutic Medication and Racing Horses: A Short Course." Extended program with three guests faculty and 50+ registrants. Churchill Downs, Louisville, KY. October 31, 2000.
  29. "Medication: Then and Now." Stewards Accreditation Short Course. Univerisity of Louisville, November 13, 2000.
  30. Invited panelist, "Therapeutic Medication and the Racing Horse." The American Association of Equine Practitioners Meeting, San Antonio, Texas. November 2000.
  31. Invited speaker, Testing Integrity Program, Race Track Industry Program. Tucson, Arizona. December 2000.
  32. Therapeutic Medication & Racing Horses: A Short Course: Turfway Park, LLC, Florence, Kentucky, March 20, 2001. Guest Faculty: Dr. Mitzi Fisher, Dr. Thomas Wood; 40 registrants.
  33. Therapeutic Medication & Racing Horses: A Short Course: Turfway Park, LLC, Florence, Kentucky. March 20, 2001. Guest Faculty: Dr. Mitzi Fisher, Dr. Thomas Wood; 40 registrants.
  34. The Commission Veterinarian/Equine Medical Director 2001: A Short Course: Kentucky Derby Museum, Louisville, Kentucky. May 1-2, 2001. Extensive guest faculty; 80+registrants/participants, extensive international list of attendees.
  35. Presentation on the Mare Reproductive Loss Syndrome (MRLS), Keeneland, May 28th, 2001.
  36. Board Meeting, Thoroughbred Owners of California, Del Mar, California, Saturday, July 21st, 2001.
  37. With Dr. Levent Dirikolu, presentation on Formulation Strategies for Clazuril Anti- Protozoals, Bayer Animal Health, Kansas City, Kansas, August 10th, 2001.
  38. "Zero Tolerance – A Myth" presentation to the Board of the National Horsemen’s Benevolent and Protective Association, Copley Plaza, Boston, MA, Monday, August 13th, 2001.
  39. College of Veterinary Medicine, Cordoba, Argentina, August 16th, 17th and 18th – 14 lectures in Continuing Education Short Course, Honorary Faculty Member, College of Veterinary Medicine of the Province of Cordoba.
  40. Cordoba: History of Equine Medication Conrol: Medication Control from the early Eighteen-hundreds to today.
  41. Cordoba: Equine Drugs and Medications: Their absorption, distribution, metabolism and elimination in the horse. Equine Drug Metabolism: an overview of why chemists test horse urine. Equine Drug Testing: an overview.
  42. Cordoba: An overview of the Pharmacological Actions of Performance altering Drugs effects, including how drugs and medications are used to influence racing performance.
  43. Cordoba: The "NO Effect Threshold" concept and how "No effect Thresholds" are developed.
  44. Cordoba: The Narcotic Analgesics and their actions and detection in the Horse.
  45. Cordoba: Central Stimulant Drugs and their actions and effects.
  46. Cordoba: Selected Tranquilizers and their actions and effects (class 2 agents).
  47. Cordoba: Selected Tranquilizers and their actions and effects (class 3 agents).
  48. Cordoba: Selected Broncodilators and their actions and effects.
  49. Cordoba: Selected Non-steroidal Anti-inflamatory Medications and their actions and effects.
  50. Cordoba: Furosemide and other agents used in the control of Exercise Induced Pulmonary Hemorrhage….
  51. Cordoba: Anabolics and their actions and effects.
  52. Cordoba: The rules of the Therapeutic Road.
  53. Cordoba: Equine Protozoal Myelitis: A New Therapeutic Approach.
  54. Dubail Grass Sickness Research Group, Dubai, UAR. Presentation on "Toxicokinetics of Cyanide in the Horse", September 22nd, 2001. Dubai Millenium Medal.
  55. Chicago Hilton, Boshringer Ingelheim Working Group on Torpex. Presentation on Detection Times for Albuterol after Administration by Torpex. October 16th, 2001.
  56. Keeneland Racecourse. Presentation and Press Conference on "Proposed Policy on. October 18th, 2001.
  57. Attendance and Presentations at TIP Meeting and AAEP Medication Summit, Tucson, Arizona, December 2001.
  58. "Overview of the Proposed Policy on Drug Testing and Medication Control," Las Vegas, Nevada, Tuesday, January 22nd , 2002.
  59. "An Overview of MRLS", Karakata Sales Complex, Karakata, New Zealand. Sponsored by the University of Auckland, January 26th, 2002.
  60. "An Overview of Equine Medication Research". Presented to the Board of the Florida HBPA, Gulfstream Park, February 14th , 2002.
  61. Equine Medication Control Thresholds: An Overview. The Conference Center, Bank of Nova Scotia, Kingston, Jamaica, April 18th, 2002.
  62. Furosemide and EIPH: An Overview. The Conference Center, Bank of Nova Scotia, Kingston, Jamaica, April 18th, 2002.